EUVIMEDEUVIMED entdecken
Crossref

Exploring the miRNA-126 and IL-21 Regulatory Pathway in Rheumatoid Arthritis Patients

Ahmed Abdulridha Ameen Shlash

Current Research in Health Sciences · 2026

DOI: 10.58613/crhs422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Research in Health Sciences, 2026. Verfasst von Ahmed Abdulridha Ameen Shlash.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rheumatoid arthritis (RA) is a chronic autoimmune disease driven by a network of pro-inflammatory cytokines and epigenetic regulators that together sustain synovial inflammation and joint damage. Interleukin-21 (IL-21), produced mainly by T follicular helper and Th17 cells, has been implicated in the activation of synovial fibroblasts, osteoclastogenesis and autoantibody production, while microRNA-126 (miRNA-126) has emerged as a regulator of immune cell signalling with reported, though inconsistent, alterations in RA synovial tissue. Whether circulating levels of these two molecules move together in RA patients has not been well characterised.

Objective

To measure serum IL-21 concentration and relative miRNA-126 expression in RA patients compared with healthy controls, to evaluate their association with rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibody status, to test the correlation between the two markers, and to assess their individual diagnostic performance.

Method

Fifty RA patients recruited from teaching hospitals and outpatient clinics in Najaf, Iraq, and forty age- and sex-comparable healthy controls were enrolled. RF was assessed by latex agglutination and anti-CCP antibody by ELISA. Serum IL-21 was measured by sandwich ELISA. Total RNA was extracted from serum and reverse-transcribed, and miRNA-126 relative expression was determined by one-step RT-qPCR using U6 as the reference gene and the 2∧-ΔΔCt method.

Results

RA patients had significantly higher serum IL-21 (178.2 ± 42.4 ng/L versus 126.6 ± 14.0 ng/L, p

Zitieren

APA

Shlash, A. A. A. (2026). Exploring the miRNA-126 and IL-21 Regulatory Pathway in Rheumatoid Arthritis Patients. Current Research in Health Sciences. https://doi.org/10.58613/crhs422

Vancouver

Shlash AAA. Exploring the miRNA-126 and IL-21 Regulatory Pathway in Rheumatoid Arthritis Patients. Current Research in Health Sciences. 2026. doi:10.58613/crhs422

BibTeX
@article{Shlash2026,
  author = {Shlash, Ahmed Abdulridha Ameen},
  title = {Exploring the miRNA-126 and IL-21 Regulatory Pathway in Rheumatoid Arthritis Patients},
  journal = {Current Research in Health Sciences},
  year = {2026},
  doi = {10.58613/crhs422}
}
Kostenlos starten →